U.S., EU clear manufacturing plant for Bavarian Nordic's monkeypox vaccine
Drugmaker Bavarian Nordic said U.S. and European regulators have approved the use of Jynneos vaccine doses made at the company's plant in Denmark as global efforts to tackle the monkeypox outbreak pick up pace.
Reuters ·
Reuters
